European Commission approves Keytruda plus Trastuzumab and chemotherapy as first-line treatment for GEJ
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Hospital joins with Intuitive to install da Vinci systems to support enhanced healthcare delivery and patient outcomes across India
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Aims to build the largest connected healthcare ecosystem in India
The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
Subscribe To Our Newsletter & Stay Updated